Thomas Matthew P, Altman Ashley, Magovern George J, Moraca Robert J
Department of Thoracic and Cardiovascular Surgery, Allegheny General Hospital, Pittsburgh, Pennsylvania 15212, USA.
J Card Surg. 2013 Jul;28(4):469-71. doi: 10.1111/jocs.12118. Epub 2013 May 15.
Post-cardiotomy cardiogenic shock is an infrequent devastating complication with few options for support.
We present a case highlighting use of the Impella 5.0 (ABIOMED; Danvers, MA) for postcardiotomy cardiogenic shock after coronary artery bypass and bioprosthetic aortic valve replacement.
Support was maintained for 7 days before being successfully weaned with myocardial recovery and no damage to the bioprosthetic aortic valve.
This is the first published report of successful use of an Impella 5.0 (ABIOMED; Danvers, MA) for post-cardiotomy cardiogenic shock through a new implanted bioprosthetic aortic valve.
心脏术后心源性休克是一种罕见的毁灭性并发症,支持治疗选择有限。
我们报告一例病例,突出展示了在冠状动脉搭桥术和生物人工主动脉瓣置换术后,使用Impella 5.0(美国马萨诸塞州丹弗斯市ABIOMED公司)治疗心脏术后心源性休克的情况。
维持支持治疗7天,随后成功撤机,心肌恢复,生物人工主动脉瓣未受损。
这是首次发表的关于通过新植入的生物人工主动脉瓣成功使用Impella 5.0(美国马萨诸塞州丹弗斯市ABIOMED公司)治疗心脏术后心源性休克的报告。